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Synthesis and conformational studies of novel chiral 
macrocyclic [1.1.1]metacyclophanes containing benzofuran 
rings 
Md. Monarul Islam,a  Tomiyasu Hirotsugu,a Taisuke Matsumoto,b Junji Tanaka,b 
Shofiur Rahman, Paris E. Georghiou, Carl Redshawc and Takehiko Yamato*a 
Macrocyclic [1.1.1]metacyclophanes (MCPs) containing benzene and benzofuran rings linked by 
methylene bridge, which can be viewed as calixarene analogs, have been synthesized by demethylation 
of [3.3.1]MCP-diones with trimethylsilyl iodide (TMSI) in MeCN. [3.3.1]MCP-diones are synthesized 
by using (p-tolylsulfonyl)methyl isocyanide (TosMIC) as the cyclization reagent in N,N-
dimethylformamide (DMF) with an excess of sodium hydride. 1H NMR spectroscopy revealed that the 
remaining one hydroxyl group forms intramolecular hydrogen bonding with the oxygen of a benzofuran 
ring. O-Methylation at the lower rim of monohydroxy[1.1.1]MCP in the presence of K2CO3 in acetone 
afforded a novel and inherently chiral  calixarene analog, namely the macrocyclic [1.1.1]MCP, 
possessing C1 symmetry. The inherent chirality of the two conformers was characterized by 1H NMR 
spectroscopy by addition of an excess of Pirkle's chiral shift reagent [(S)-(+)-1-(9-anthryl)-2,2,2-
trifluoroethanol], which caused a splitting of the corresponding methylene protons to AB patterns.  
Single crystal analysis revealed the adoption of a hemisphere-shaped cone isomer. DFT calculations 
were carried out to investigate the energy minimized structure and hydrogen bonds of the synthesized 
MCPs. 
Introduction 
The design and synthesis of novel and functional macrocycles such 
as cyclophanes1 and calix[n]arenes2 have been of particular synthetic 
and theoretical interest among scientists for a number of decades. 
Chiral calixarenes have attracted recent attention due to their 
potential use as enantio-selective artificial receptors and asymmetric 
catalysts.3 Two principal approaches have been used for the 
preparation of chiral calixarenes. The first one is synthesis of 
inherently chiral calixarenes,4 whilst the second approach is via 
attachment of chiral moieties at the upper or lower rim of a 
calixarene macrocycle.5 Since the first unintentional preparation of 
inherently chiral calixarenes was reported by Kwang and 
Gutsche,6 inherently chiral calixarenes have continued to attract 
attention.7 Given their peculiar structures and unique conformational 
properties, inherently chiral calixarenes have become topical 
macrocyclic molecules.8
      The concept of “inherently chirality” was first suggested by 
Böhmer, whose chirality was based on the absence of planar 
symmetry or an inversion centre in molecules bearing an asymmetric 
array of several achiral groups appended to their three-dimensional 
skeletons.9 This concept was soon accepted by researchers and 
further developed by Mandolini and Schiaffino.10 Indeed, inherently 
chiral macrocycles with diverse structures could be obtained from 
asymmetric arrays of one or several functionalities on the 
cyclophane/calixarene skeletons in appropriate positions. The 
synthesis and optical resolution of inherently chiral calixarenes are 
challenging yet attractive, because of their potential uses in 
supramolecular chemistry.11 In this aspect, the design and synthesis 
of inherently chiral calixarenes with novel structures and superior 
functions are a topic of great importance. Inherently chiral 
calixarenes are receiving increasing attention due to their intriguing 
structures and potential applications in chemical, analytical, 
biological and material fields.12
      Most recently, Szumna modified the definition as ‘inherent 
chirality arises from the introduction of a curvature in an ideal planar 
structure that is devoid of perpendicular symmetry planes in its bi-
dimensional representation’.13 A wide variety of concave molecule-
based inherently chiral macrocycles such as calixarenes,14 
resorcinarenes,15 heteracalixaromatics,16 cyclotriveratrylenes,17 and 
so on,13 have been reported and many of these have shown excellent 
chiral recognition and asymmetric catalytic abilities. An inherently 
chiral element can also be added to concave molecules consisting of 
repeating chiral subunits such as cyclodextrins as reported by 
Sollogoub.18 However, access to inherently chiral calixarenes is 
frequently not straightforward due to regio-control and 
conformational problems involved at the synthetic stage, and 
consequently low yields result. Therefore, the development of 
effective methods for the synthesis of enantiomerically pure 
inherently chiral calixarenes and the determination of their absolute 
configuration is of great importance. 
It is surprising that reports on the preparation of calixarenes and their 
analogs containing three arene rings and the characterization of their 
hydrogen bonding has been very limited.19 Our group has reported 
various types of meta cyclophanes20 and oxahomocalixarenes21 
containing three benzene rings.  
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      We report herein a short and easy route for the synthesis of 
inherently chiral macrocyclic[1.1.1]MCPs containing 
both benzene and benzofuran rings in good yield.   
Scheme 1 Demethylation of 6,15,22-tri-tert-butyl-9,18,25-trimethoxy[3.3.1]MCP-2,11-dione 3.
Results and Discussion 
As part of our continued interest in the synthesis of novel structures 
of the inherently chiral calixarenes analogs MCP, we undertook a 
systematic investigation of [1.1.1]MCPs containing both benzene 
and benzofuran rings, which were synthesized by intramolecular 
cyclization. The macrocyclic MCP framework 3 was synthesized by 
the reaction between the TosMIC [(TosMIC = (p-
tolylsulfonyl)methyl isocyanide)] adduct 1 and 1,1-bis(3-
bromomethyl-5-tert-butyl-2-methoxyphenyl)- methane 2. Vögtle and 
co-workers22 reported the preparation of carbocyclic [3n]MCPs using 
TosMIC23 as the cyclization reagent, which was applied in a new 
cyclization procedure without phase-transfer conditions.24 
      Treatment of 6,15,22-tri-tert-butyl-9,18,25-trimethoxy- 
[3.3.1]MCP-2,11-dione 3 with TMSI generated in situ from 
TMSCl and NaI in CH3CN afforded the furan moiety by 
nucleophilic intramolecular cyclization. Sawada and co-
workers reported that treatment of tetrahydroxy-tetramethoxy 
[2.1.2.1]MCPs with TMSI lead to hemisphere-shaped 
calixarene analogs containing a dihydrobenzofuran ring.25 The 
structures of 4 (symmetrical or unsymmetrical) were 
determined by spectroscopic methods (1H NMR and 13C NMR), 
Mass and elemental analyses. The crude 1H NMR spectrum 
after reaction with TMSI exhibited two kinds of signal, namely 
singlets for the hydroxyl groups (exchanged by D2O) and furan 
moieties. By careful column chromatography, using hexane-
CH2Cl2 (8:2) as  eluent, the symmetrical-15,35,55-tri-tert-butyl-
12-hydroxy-1-(1,3)-benzena-3,5-
(2,7)benzofuranacyclohexaphane 4a (24 %) was isolated, whilst 
hexane-CH2Cl2 (1:1) as eluent gave unsymmetrical-15,35,55-tri-
tert-butyl-12-hydroxy-1(1,3)-benzena-3,5-
(2,7)benzofuranacyclohexaphane 4b (45 %) as the major 
product. The structures of 4a and 4b have been elucidated on 
the basis of their spectroscopic data. The calixarenes show 
concentration independent hydroxyl stretching bands in the 
3200 cm-1 region of the infrared spectrum and a signal at δ 6–7 
ppm in the 1H NMR spectrum, indicative of very strong 
intramolecular hydrogen bonding characteristic of the cyclic 
nature of calixarenes.2,26 The 1H NMR spectrum (CDCl3, 300 
MHz) of 4a exhibits the signal for the hydroxyl groups at δ 6.54 
ppm (exchanged by D2O). Such data is consistent with the 
existence of intramolecular hydrogen bonding between the 
hydroxyl group and the oxygen of the benzofuran ring. The 1H 
NMR spectrum of macrocycle 4a exhibits two sets of doublets 
at δ 3.93 and 4.86 ppm (J = 13.3 Hz) for the ArCH2Ar methy-
lene protons. These patterns correspond to the "cone" 
conformer given the two methylene protons ArCH2Ar are in 
different environments. The remaining two bridge methylene 
protons appeared as a doublet at δ 3.63 (J = 13.8 Hz) and 4.66 
ppm (J = 13.5 Hz). The structure of 4a was also established by 
single crystal X-ray analysis (CCDC 1049029), the crystals for 
which were grown from a hexane-CHCl3 1:1 mixture by slow 
evaporation. The crystal structure was found to belong to the 
orthorhombic crystal system with space group Pccn (SI Table 
S1) and is fully consistent with the 1H NMR data of 4a. 
      It is clear that the one hydroxyl group present between the 
two benzofuran rings forms an intramolecular hydrogen bond 
with the oxygen of the benzofuran ring as predicted from the 1H 
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NMR spectroscopic data. The distance between H3 (OH) and 
Ol is 2.182 Å, which is a reasonable distance for intramolecular 
hydrogen bonding and less than that between H3 (OH) and O2 
at 2.523 Å. A concentration variable 1H NMR study of 4a 
(CDCl3, 400 MHz) from 0.5 mM to 30 mM at 25 ºC shows that 
the hydroxyl proton  
Fig. 1 Ortep drawing of 4a with top (top) and side (bottom) views. 
Thermal ellipsoids are drawn at the 50% probability level. All hydrogen 
atoms except one are omitted for clarity. 
peak is concentration independent and always exhibits a peak at 
δ 6.50 ppm (SI, Fig. S23). On increasing the concentration of 
4a from 0.5 mM to 30 mM only the hydroxyl proton peak 
intensifies, which is evidence for the intramolecular hydrogen 
bonding. We also studied the intramolecular hydrogen bonding 
of 4a and 4b in different polar solvents. The 1H NMR spectrum 
of 4a (400 MHz) in a mixture of CD3OD and CDCl3 (9:1) led 
to a shift for the hydroxyl peak at δ 7.66 ppm, indicating that 
the intramolecular hydrogen bonding is disrupted in polar 
solvents (SI, Fig. S25). The 1H NMR (CDCl3, 300 MHz) 
spectrum of macrocycle 4b possessed three single peaks for the 
tert-butyl protons at δ  1.13, 1.31 and1.32 ppm (relative 
intensity 1:1:l) and two single peaks for the furan ring at δ 6.36 
and 6.39 ppm.  
 The macrocycle 4b is fixed in the form of a symmetrical 
hemisphere-shaped cone conformation at room temperature as 
observed by the four sets of doublets for the methylene protons 
at δ 4.02 (J = 14.7 Hz), 4.51 (J = 14.7 Hz), 4.66 (J = 13.2 Hz) 
and 4.97 (J = 13.2 Hz) ppm. The 1H NMR spectrum (CDCl3, 
300 MHz) exhibits a signal for the hydroxyl group at δ 6.55 
ppm (exchanged by D2O), indicative of a similar 
intramolecular hydrogen bonding between hydroxyl group with 
oxygen of benzofuran ring. The IR (KBr) spectrum of 4b shows 
the absorption for the hydroxyl stretching vibration around 
3651 cm-1 due to hydrogen bonding. The concentration 
variable 1H NMR study of 4b (CDCl3, 400 MHz) from 0.5 mM 
to 30 mM at 25 ºC shows that hydroxyl proton peak is 
concentration independent and always gives peak at δ 6.55 ppm 
(SI, Fig. S24) 
Scheme 2 O-Methylation of hydroxy[1.1.1]MCPs 4 with MeI in the 
presence of K2CO3. 
result to that of 4a. In the slightly more polar solvent 
CD3COCD3 (versus CDCl3), the hydroxyl peak shifted to 6.86 
ppm. The 1H NMR spectrum of 4b (400 MHz) in a mixture of 
CD3OD-CDCl3(9:1) led to a shift of the hydroxyl peak at 
δ 7.68 ppm, indicating that the intramolecular hydrogen 
bonding is disrupted in the polar solvent (SI, Fig. S26). Along 
with 4a and 4b, we succeeded in isolating another compound 
4c from the hexane eluent of the column chromatography. The 
structure was somewhat peculiar, containing one furan ring and 
two dihydrofuran moieties in the cyclophane frame. The 
presence of the cyclophane structure was evident from the 1H 
NMR signals observed for the bridge methylene hydrogen 
atoms that appeared as two pairs of doublets at δ 4.21 and 4.39 
ppm. The 1H NMR spectrum of macrocycle 4c showed three 
single peaks for the tert-butyl protons at δ 1.22, 1.28 and 1.36 
ppm (relative intensity 1:1:1). It is difficult to say how the two 
dihydrofuran moieties were formed, and we tentatively propose 
that two phenolic oxygens compete at once for nucleophilic 
attack at the same carbon thereby leading to the formation of 
the dihydrofuran moieties. 
ppm 
4.00 4.50 
(A) 
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Fig. 2 Partial 1H NMR spectra (CDCl3; 400 MHz); (A) 5b, (B) 5b + 
Perkle’s reagent. 
Fig. 3 Molecular structures of the P-enantiomer (left) and M-enantiomer (right) of  5b with top (top) and side (bottom) views. Thermal ellipsoids 
are drawn at the 50 % probability level. All hydrogen atoms are omitted for clarity. 
Although we failed to isolate the intermediate 4', from examination 
of the crystal structure of the parent compound 3 (SI, Fig. S27), it is 
evident that the distance between O3-C5 (3.210 Ǻ) is less than that 
of O2-C5 (3.510 Ǻ) and O3-C20 (3.685 Ǻ). Thus, the O3 oxygen 
has a high chance for nucleophilic attack at C5 carbon and after that 
there is only the one opportunity for the oxygen O1 to attack at the 
C20 carbon to form the cyclic furan ring. Another factor which leads 
to the high yield of 4b is that if O2 oxygen attacks at C5 carbon, 
then there is also one prior opportunity for the O3 oxygen to attack 
at the C20 carbon than the O1 oxygen. If O1 oxygen attack occurs at 
C20 carbon then it would lead to a low yield of the symmetrical-
15,35,55-tri-tert-butyl-12-hydroxy-1-(1,3)-benzena-3,5-
(2,7)benzofuranacyclohexaphane 4a. 
      O-Methylation of 4b by MeI in the presence of K2CO3 in 
acetone afforded the desired calixarene analog, namely the 
inherently chiral metacyclophane 15,35,55-tri-tert-butyl-12-methoxy-
1-(1,3)benzena-3,5-(2,7)benzofuranacyclohexaphane 5b. The 1H 
NMR spectrum (CDCl3, 300 MHz)  of macrocycle 5b revealed three 
single peaks for the tert-butyl protons at δ 1.11, 1.31 and 1.34 ppm 
(relative intensity 1:1:l) and two singlet peaks at δ 6.32 and 6.35 
ppm for the furan ring. Compound 5b forms an asymmetric hemi-
sphere shaped "cone" conformation at room temperature as by the 
observation of two sets of doublets for the methylene protons and the 
methoxy group is pointed upward and deshielded at δ 3.83 ppm. 
Inherent chirality is a unique feature associated with MCP and 
macrocycle 5b is expected to have a plane of chirality, because it has 
two types of substituents and bridged linkages which are fixed as a 
C1 symmetrical conformer and does not undergo a conformational 
change at or near ambient temperature. 
Böhmer and co-workers27 demonstrated the chirality of 
dissymmetric calix[4]arenes with C2 and C4 symmetry by 
interaction with Pirkle's reagent [(S)-(+)-1-(9-anthryl)-2,2,2-
trifluoroethanol]. The 1H NMR spectrum of compound 5b in the 
absence and the presence of Pirkle's reagent is shown in Fig. 3. 
Addition of Pirkle’s reagent to the racemic mixture (P-enantiomer 
and M-enantiomer) splits the signals in the 1H NMR spectrum due to 
the formation of two diastereomeric complexes. 
M P 4 | J. Name., 2013, 00, 1-3 This journal is © The Royal Society of Chemistry 2013 
Journal Name ARTICLE 
Fig. 4 Schematic diagram of M-5b (left) and P-5b (right). 
Fig. 5  DFT B3LYP/6-31+G(d) optimized molecular structure of (a) 4a, (b) 4b, (c) 5a and (d) 5b. 
Fortunately, 5b gave high quality single crystal (CCDC 1049090) 
from a hexane-CHCl3 1:1 mixture. The X-ray molecular structure, 
depicted in Fig. 4, revealed that the macrocyclic skeleton adopts a 
highly asymmetric hemisphere shaped "cone" conformation. The 
crystal structure was found to belong to the monoclinic crystal 
system with space group C2/c (SI Table S1). From the single crystal 
analysis (Fig. 4), it is clear that the methoxy group is pointed 
upwards and is outside of the two benzofuran rings as predicted from 
the 1H NMR spectrum. As illustrated explicitly in Fig. 4, P-5b and 
M-5b are mirror images of one another, but they cannot be 
superimposed. 
      O-Methylation of 4a with MeI in the presence of K2CO3 in 
acetone resulted in the inversion of the arene ring affording the 
partial-cone methoxy[1.1.1]MCPs 5a. This is evident from the 1H 
signals observed for the bridge methylene hydrogen atoms that are 
split and appear as a pair of doublets at δ 3.07 and 3.58 ppm for 5a. 
The 1H NMR spectrum of macrocycle 5a exhibited two singlet peaks 
for the tert-butyl protons at δ = 1.04 and 1.24 ppm (relative intensity 
1:2). The methoxy group for compound 5a shifted to high field as a 
single peak at δ 1.97 ppm due to the methoxy group residing inside 
of the two benzofuran rings and experiencing shielding due to the 
ring current. To better understand the geometry-optimized energy of 
compounds 4a, 4b, 5a and 5b, computational studies were carried 
out. The individual structures for all studies in the gas-phase were 
fully geometry-optimized using Gaussian 09 with the B3LYP level 
of density functional theory (DFT) calculations and the 6-31G(d) 
basis set.30 The observed geometry-optimized energies (E kJ mole-1) 
for compounds 4a, 4b, 5a and 5b are shown in Table 1. From the 
optimized geometrical molecular structure of compound 4a (Fig. 5), 
it is seen that the distance between O1---H3 is 1.999 Å less than that 
of O2---H3 which is almost equal to the distance calculated from the 
single crystal analysis [2.182 Å]. 
Although we failed to obtain single crystals of 4b, the hydrogen 
bond distance was calculated from the DFT optimized structure (Fig. 
5) and the distance is 2.018 Å, which is a reasonable distance for the
intramolecular hydrogen bonding. The DFT B3LYP optimized 
structure of 5a indicated that it adopted a hemi-sphere shaped cone 
conformation and that the methoxy group is position upwards. 
Table 1 DFT B3LYP6-31G(d) optimized energies of the synthesized MCPs. 
However in solution it forms a partial-cone conformation which 
is evident by the high field shift of the methoxy group at δ 1.97 ppm 
and methylene bridge pattern in the 1H NMR spectrum (300 MHz, 
CDCl3). Both the single crystal and DFT optimized structures of 5b 
indicate that it adopts a hemisphere shaped cone conformation and 
that the methoxy group is pointed up, outside of the benzofuran rings 
(Fig. 3 and Fig. 5). DFT B3LYP optimized energies of the 
synthesized MCPs showed that 4a and 4b are more stable due to the 
presence of the intramolecular hydrogen bonding. 
Compound 
Geometry-optimized 
energy (kJ mole-1) 
4a -4360789.8962 
4b -4360792.5746 
5a -4463957.4525 
5b -4463947.4704 
a 
c 
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Conclusion 
In summary, we have developed an efficient and straightforward 
strategy for the construction of inherently chiral methylene-bridged 
calixarene analogs, namely metacyclophanes containing benzofuran 
rings. The benzofuran rings are formed by a simple intramolecular 
nucleophilic cyclization reaction of [3.3.1]meta- cyclophane-2,11-
dione with TMSI. The 1H NMR spectroscopy and X-ray analysis of 
5b confirmed that it adopted a hemi-sphere shaped cone 
conformation both in solution and the solid state. We believe that the 
presently developed novel inherently chiral [1.1.1]metacyclophane 
will find practical applications as an enantioselective artificial 
receptor and in asymmetric synthesis; such studies are now in 
progress in our laboratory. 
Experimental 
General 
All melting points (Yanagimoto MP-S1) are uncorrected. Proton 
nuclear magnetic resonance (1H NMR) spectra were recorded on a 
Nippon Denshi JEOL FT-300 spectrometer. Chemical shifts are 
reported as δ values (ppm) relative to internal Me4Si. Mass spectra 
were obtained on a Nippon Denshi JMS–01SA–2 mass spectrometer at 
ionization energy of 70 eV; m/z values reported include the parent ion 
peak. Infrared (IR) spectra were obtained on a Nippon Denshi JIR-
AQ2OM spectrophotometer as KBr disks. Elemental analyses were 
performed by Yanaco MT-5. G.L.C. analyses were performed by 
Shimadzu gas chromatograph, GC-14A; Silicone OV–1, 2 m; 
programmed temperature rise, 12 °C min-1; carrier gas nitrogen, 25 mL 
min-1. Silica gel columns were prepared by use of Merk silica gel 60 
(63–200 μm). 
Materials 
6,15,22-Tri-tert-butyl-9,18,25-trimethoxy[3.3.1]metacyclophane-2,11-
dione 3 was prepared by the reaction of 2,6-bis(bromomethyl)-4-tert-
butylanisole TosMIC adduct 1 with 1,1-bis(5-tert-butyl-2-methoxyphenyl)- 
methane 2 according to a reported procedure. 20d,28,29 
Demethylation of 3 withTMSI 
To a solution of 3 (368 mg, 0.6 mmol) in CH3CN (20 mL), NaI (1.8 g, 12.0 
mmol) was added. After adding trimethylsilyl chloride (1.6 mL, 12.0 mmol), 
the mixture was stirred at 80–85 °C for 48 h. The reaction mixture was 
quenched with 40 mL ice water and 10 % aqueous sodium thiosulphate 
solution (80 mL) was added and stirred 1 h at room temperature. Then the 
mixture was stirred with 10 % HCl (40 mL) for 1 h and extracted with 
CH2Cl2 (3 × 80 mL). The combined extracts were washed with 10 % 
NaHCO3 (40 mL), water (40 mL × 2) and dried over MgSO4 and 
concentrated under reduced pressure. The residue was chromatographed on 
silica gel using hexane-CH2Cl2 (8:2) as eluents to give crude symmetrical 
15,35,55-tri-tert-butyl-12-hydroxy-1-(1,3)-benzena-3,5-
(2,7)benzofuranacyclohexaphane 4a and hexane-CH2Cl2 (1:1)  as eluents to 
give unsymmetrical 15,35,55-tri-tert-butyl-12-hydroxy-1(1,3)-benzena-3,5-
(2,7)benzofuranacyclohexaphane 4b.  
Symmetrical 15,35,55-tri-tert-butyl-12-hydroxy-1-(1,3)-benzena-3,5(2,7) 
benzofuranacyclohexaphane 4a 
Recrystallisation from hexane afforded symmetrical 15,35,55-tri-tert-butyl-12-
hydroxy-1-(1,3)-benzena-3,5(2,7)benzofuranacyclohexaphane 4a (96 mg, 24 
%) as colourless prisms. M.p. 300–301 °C. IR: νmax (KBr)/cm-1: 3543 
(OH). 1H NMR (300 MHz, CDCl3): δ= 1.18 (9H, s, tBu), 1.30 (18H, s, tBu × 
2), 3.63 (2H,d, J = 13.8, CH2), 3.93 (1H, d, J = 13.2 Hz, CH2), 4.66 (2H, d, J 
= 13.5 Hz, CH2), 4.86 (1H, d, J = 13.2 Hz, CH2), 6.36 (2H, s, Ar–H), 6.54 
(1H, s, OH, Exchanged by D2O), 6.97 (2H, s, Ar–H),7.23 (2H, d, J = 2.1 Hz, 
Ar–H) and 7.39 (2H, d, J = 1.8 Hz, Ar–H) ppm. 13C NMR (100 MHz, 
CDCl3): δ = 29.02, 31.26, 31.41, 31.84, 34.12, 34.59, 102.14, 114.85, 
122.09, 122.82, 125.34, 128.08, 129.84, 145.73, 146.04, 150.46, 150.79 and 
158.92 ppm. FABMS: m/z: 534.34 [M+]. C37H42O3 (534.73): calcd C 83.11, 
H 7.92; found: C 82.95, H 7.81. 
Unsymmetrical 15,35,55-tri-tert-butyl-12-hydroxy-1-(1,3)-benzena-3,5-
(2,7)benzofuranacyclohexaphane 4b 
Recrystallisation from hexane afforded unsymmetrical 15,35,55-tri-tert-butyl-
12-hydroxy-1-(1,3)-benzena-3,5-(2,7)benzofuranacyclohexaphane 4b (181 
mg, 45 %) as colourless prisms. M.p. 279–280 °C. IR: νmax (KBr)/cm-1: 3651 
(OH). 1H NMR (300 MHz, CDCl3): δ= 1.13 (9H, s, tBu), 1.31 (9H, s, tBu), 
1.32 (9H, s, tBu), 3.63 (2H,d, J = 13.8, CH2), 4.02 (1H, d, J = 14.7 Hz, CH2), 
4.51 (1H, d, J = 14.4 Hz,CH2), 4.66 (1H, d, J = 13.8 Hz, CH2), 4.97 (1H, d, J 
= 13.2 Hz, CH2), 6.36 (1H, s, Ar–H),6.39 (1H, s, Ar–H), 6.55 (1H, s, OH, 
Exchanged by D2O), 6.91 (1H, d, J = 2.1 Hz, Ar–H), 7.03 (1H, d, J = 2.4 Hz, 
Ar–H), 7.12 (1H, d, J = 1.8 Hz, Ar–H), 7.21 (2H, d, J = 0.9 Hz, Ar–H) and 
7.31 (1H, d, J = 1.8 Hz, Ar–H) ppm. 13C NMR (100 MHz, CDCl3): δ = 
31.27, 31.35, 31.50, 31.82, 31.88, 32.40, 34.05, 34.56, 34.67, 101.69, 103.85, 
114.67, 115.90, 120.52, 121.44, 122.09, 122.21, 124.63, 125.20, 125.35, 
128.24, 128.84, 129.68, 131.53, 145.52, 146.22, 146.28, 148.79, 156.31 and 
159.07 ppm. FABMS: m/z: 534.33 [M+]. C37H42O3 (534.73): calcd C 83.11, 
H 7.92; found: C 82.80, H 7.91. 
15,25,45-tri-tert-butyl-12-1,2-di-(2,7)dihydrobenzofurana-4(2,7)benzo- 
furanacyclopentaphane 4c 
Recrystallisation from hexane afforded 15,25,45-tri-tert-butyl-12-1,2-di-
(2,7)dihydrobenzofurana-4-(2,7)benzofuranacyclopentaphane 4c (20 mg, 5 
%) as colourless prisms. M.p. 251–252 °C. 1H NMR (300 MHz, CDCl3): δ= 
1.22 (9H, s, tBu), 1.28 (9H, s, tBu),1.36 (9H, s, tBu),3.38-3.50 (4H,m, 
CH2CCH2), 3.59 (1H,d, J = 15.3, CH2), 3.66 (1H, d, J = 15.0 Hz, CH2), 4.21 
(1H, d, J = 15.3 Hz,CH2), 4.39 (1H, d, J = 13.5 Hz, CH2), 6.33 (1H, s, Ar–
H),6.99(2H, s, Ar–H),7.15 (2H, d, J = 6.3 Hz, Ar–H) and 7.30 (2H, s, Ar–H) 
ppm. 13C NMR (100 MHz, CDCl3): δ = 29.93, 31.57, 31.70, 31.78, 31.93, 
34.33, 34.42, 34.57, 37.71, 37.81, 101.46, 114.58, 118.80, 119.86, 120.68, 
120.88, 121.20, 121.69, 124.26, 125.14, 125.59, 125.90, 126.58, 128.51, 
139.31, 144.31, 144.52, 145.23, 154.63, 156.04 and 156.56 ppm. FABMS: 
m/z: 534.34 [M+]. C37H42O3 (534.73): calcd C 83.11, H 7.92; found: C 82.94, 
H 7.75. 
O-Methylation of 6b with MeI in the presence of K2CO3 
A mixture of 4b (100 mg, 0.18 mmol) and potassium carbonate (258 mg, 1.8 
mmol) in dry acetone (12 mL) was heated at reflux for 1 h under N2. Then 
MeI (0.12 mL, 1.8 mmol) was added and the mixture heated at reflux for 12 
h. After cooling of the reaction mixture to room temperature, it was quenched 
with water, and extracted with CH2Cl2 (20 mL× 2). The combined extracts 
were washed with water (10 mL × 2), dried over MgSO4 and condensed 
under reduced pressure and the residue was chromatographed on silica gel 
(Wako, C-300; 100 g) by using CHCl3 as eluent to give the crude 5b (78 mg, 
79 %) as a colourless solid. Recrystallization from hexane gave 
unsymmetrical 15,35,55-tri-tert-butyl-12-methoxy-1-(1,3)-benzena-3,5-
(2,7)benzofurana-cyclohexaphane 5b as colourless prisms. M.p. 247–248 
°C. 1H NMR (300 MHz, CDCl3): δ= 1.11 (9H, s, tBu), 1.31 (9H, s, tBu), 1.34 
(9H, s, tBu), 3.67 (2H, dd, J = 13.5, 14.4 Hz, CH2), 3.83 (3H, s, OCH3), 3.95 
(1H, d, J = 14.1 Hz, CH2), 4.43 (2H, dd, J = 14.1, 14.4 Hz, CH2), 4.75 (1H, 
d, J = 13.5 Hz, CH2), 6.32 (1H, s, Ar–H), 6.35 (1H, s, Ar–H), 6.91 (1H, d, J 
= 2.4 Hz, Ar–H), 6.97 (1H, d, J = 2.4 Hz, Ar–H), 7.06 (1H, d, J = 1.8 Hz, 
Ar–H), 7.18 (1H, d, J = 1.8 Hz, Ar–H), 7.20 (1H,  d, J = 1.5 Hz, Ar–H) and 
7.29 (1H,  d, J = 1.8 Hz, Ar–H) ppm. 13C NMR (100 MHz, CDCl3): δ= 
30.83, 31.28, 31.36, 31.63, 31.89, 31.93, 34.04, 34.51, 34.60, 62.16, 101.08, 
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102.93, 114.41, 115.46, 120.74, 121.12, 121.47, 124.86, 125.39, 126.60, 
128.56, 128.87, 129.74, 131.94, 145.19, 145.37, 146.00, 151.27, 151.58, 
156.39, 157.01 and 158.38 ppm. FABMS: m/z: 548.37 [M+]. C38H44O3 
(548.33): calcd C 83.17, H 8.08; found: C 82.93, H 8.15. 
Similarly, symmetrical15,35,55-tri-tert-butyl-12-methoxy-1(1,3)benzena-
3,5(2,7)benzofuranacyclohexaphane 5a  was prepared. 
Symmetrical 15,35,55-tri-tert-butyl-12-methoxy-1-(1,3)-benzena-3,5-(2,7) 
benzofuranacyclohexaphane 5a 
Recrystallisation from hexane afforded symmetrical15,35,55-tri-tert-butyl-12-
methoxy-1-(1,3)-benzena-3,5-(2,7)benzofuranacyclohexaphane 5a (72 mg, 
75 %) as colourless prisms. M.p. 271–272 °C.1H NMR (300 MHz, CDCl3): 
δ= 1.04 (9H, s, tBu), 1.24 (18H, s, tBu × 2), 1.97 (3H, s, OCH3), 3.07 (1H, d, 
J = 10.8,CH2), 3.58 (1H, d, J = 13.5 Hz, CH2), 3.88 (2H, d, J = 13.8 Hz, 
CH2), 4.32 (1H, d, J = 14.4,CH2), 4.68 (1H, d, J = 13.5,CH2), 6.25 (2H, s, 
Ar–H), 6.99 (2H, s, Ar–H), 7.12 (2H, d, J = 6.9 Hz, Ar–H) and 7.22 (2H, s, 
Ar–H) ppm. 13C NMR (100 MHz, CDCl3): δ = 28.58, 29.91, 31.42, 31.58, 
31.76, 33.93, 34.14, 58.24, 101.47, 114.25, 124.30, 125.20, 126.80, 127.57, 
128.14, 136.34, 143.14, 149.14, 154.16 and 158.38 ppm. FABMS: m/z: 
548.37 [M+]. C38H44O3 (548.33): calcd C 83.17, H 8.08; found: C 82.92, H 
8.08. 
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